Evidence map›Paper›PMID 23247071›Full record

ReviewMolecular and cellular neurosciences2013

CUG-BP, Elav-like family (CELF)-mediated alternative splicing regulation in the brain during health and disease.

Andrea N Ladd

Abstract readReview
In one paragraph

Review in Molecular and cellular neurosciences, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. The role of alternative splicing in lung cancer.Cancer chemotherapy and pharmacology · 2023
    Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Andrea N LaddDepartment of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA. Electronic address: ladda@ccf.org.
Cleveland Clinic Lerner College of Medicine · US

Funding

Role of pre-mRNA alternative splicing programs in heart and muscle developmentR01HL089376 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI LADD, ANDREA NICOLE · 2009 to 2014
$1.7M
NHLBI NIH HHS 1R01HL089376NHLBI NIH HHS R01 HL089376
6 · The paper itself

Abstract

Alternative splicing is an important mechanism for generating transcript and protein diversity. In the brain, alternative splicing is particularly prevalent, and alternative splicing factors are highly enriched. These include the six members of the CUG-BP, Elav-like family (CELF). This review summarizes what is known about the expression of different CELF proteins in the nervous system and the evidence that they are important in neural development and function. The involvement of CELF proteins in the pathogenesis of a number of neurodegenerative disorders, including myotonic dystrophy, spinocerebellar ataxia, fragile X syndrome, spinal muscular atrophy, and spinal and bulbar muscular atrophy is discussed. Finally, the known targets of CELF-mediated alternative splicing regulation in the nervous system and the functional consequences of these splicing events are reviewed. This article is part of a Special Issue entitled "RNA and splicing regulation in neurodegeneration."

Indexed as

Alternative SplicingAnimalsBrainELAV ProteinsHumansNeurodegenerative DiseasesReceptors, NeurotransmitterELAV ProteinsReceptors, NeurotransmitterAlternative splicingAmyloid precursor proteinAPPBrainCELFCLIPCrosslinking immunoprecipitationCUG-BP, Elav-like familyDM1GABT4Gamma-aminobutyric acid transporter 4MAPTMBNLMicrotubule-associated protein tauMuscle blind-likeMyotonic dystrophyMyotonic dystrophy type 1Neurofibromin 1Neurological disordersNeuronsNF1NMDAR1N-methyl-d-aspartate receptor 1SBMASCASMASMNSpinal and bulbar muscular atrophySpinal muscular atrophySpinocerebellar ataxiaSurvival motor neuron

Identifiers

PMID23247071
PMCPMC3650117
OpenAlexW2020589121

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.